Massachusetts. Contact Information. Statistics. Technological Capabilities



Similar documents
Georgia. Contact Information. Office: Fax: Statistics. Technological Capabilities

Maryland. Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration Substance Abuse Agency

Delaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency

Washington. Contact Information. Statistics. Technological Capabilities

Illinois. Contact Information. Office: Fax: Statistics. Technological Capabilities

Idaho. Contact Information. Fax: (208) Statistics. Technological Capabilities

New Jersey. Contact Information. Statistics. Technological Capabilities

Guam. Contact Information. Statistics. Technological Capabilities

Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy

Prescribers required to check PDMP before first prescription for Controled Substances for new patient.

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA

2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS

The Massachusetts Prescription Monitoring Program

Alaska Prescription Drug Monitoring Program

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015

Prescription Drug Monitoring Programs

3.Prescriber DEA: 4.Board Registration Number: 5.Business Tel:

Prescription Drug Monitoring Program Administrators Guide for Training Law Enforcement

Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices

Prescription Drug Monitoring Programs Bill Status Update

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS

Implementation of Florida s PDMP. Rebecca Poston Program Manager

11/26/2012. Implementation of Florida s PDMP. Disclosure

CURES Prescription Drug Monitoring Program

State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program. User Support Manual

Section 303(g)(2)(G) of the Controlled Substances Act (21 U.S.C. 823(g)(2)(G)) is amended. (1) by striking clause (ii) and inserting the following:

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR. 1) Health Care Mitchell Collins 2) 3) 4) 5)

The Public Health and Safety Challenges of Treating Chronic Pain: The Medical Perspective. A Proposed CMS Platform

American Indian Health Commission for Washington State October 1, 2015

Prescription Drug Monitoring Program Annual Report

For a Healthier America: Reducing Prescription Drug Misuse and Abuse

Prescription Drug Monitoring Program. A Powerful Tool

History of Prescription Drug Monitoring Programs. PDMP Training and Technical Assistance Center Brandeis University

PRESCRIPTION DRUG ABUSE, ADDICTION AND DIVERSION: OVERVIEW OF STATE LEGISLATIVE AND POLICY INITIATIVES A THREE PART SERIES

PMP AWAR X E. User Support Manual V 1.2

Prescription Monitoring Programs: Creating a National Network

Controlled Substances Prescription Monitoring Program. Dean Wright, RPh Arizona State Board of Pharmacy

SCOPE OF PRACTICE FOR ARNPS

Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014

Pharmacy Operations. Assisting the Pharmacist. Pharmacy Technician Training Systems Passassured, LLC

MEDICAL ASSISTANCE BULLETIN

PRESCRIPTION MONITORING PROGRAM (PMP)

Pennsylvania s ABC-MAP Program

DEA's New Proposed Regulations For E-Prescribing

Subject: Health; prescription drugs; Vermont Prescription Monitoring 5 System

Report to the Legislature: Interstate Prescription Data Exchange MN Prescription Monitoring Program

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District

Medicare Compliance and Fraud, Waste, and Abuse Training

Medicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010

Re: Docket No. DEA-218, Electronic Prescriptions for Controlled Substances

South Dakota Prescription Drug Monitoring Program (SD PDMP) Learning Objectives

TABLE OF CONTENTS CHAPTER 8 PRESCRIPTION DRUG MONITORING PROGRAM

Prescription Drug Monitoring Program Center of Excellence at Brandeis

Technical Assistance Guide. PDMP Suggested Practices to Ensure Pharmacy Compliance and Improve Data Integrity

Fraud, Waste & Abuse. Training Course for UHCG Employees

OBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program

MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS

Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority:

State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations

Review of Prescription Drug Monitoring Programs in the United States

Board of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy. Disclosure. Objectives 9/9/2015

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

2015 REPORT Steven W. Schierholt, Esq. Executive Director

New Jersey State Legislative Update. Opioid Addiction and Abuse Prevention. Legislative Package Moves Forward

Massachusetts Department of Public Health (MDPH) Prescription Monitoring Program (MA PMP) and Drug Control Program (DCP) April 8, 2014

SENATE... No The Commonwealth of Massachusetts. In the Year Two Thousand Fourteen

Thank you for coming to our San Diego Workshop THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER

Mandating PDMP participation by medical providers: current status and experience in selected states

Fraud Waste and Abuse Training Requirement. To Whom It May Concern:

Training Guide for Florida Practitioners and Pharmacists

GEORGIA ~ STATUTE. Georgia Code Annotated (DEA registration); et seq; et seq (medical board provisions; PA committee)

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

Transcription:

PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vacant - Assistant Director 99 Chauncy Street Boston MA 02111 Office: (617) 753-8104 Fax: (617) 524-8062 Email: ASAP Versions Accepted ASAP 1995 ASAP 1997 ASAP 3/2005 MA Prescription Monitoring Program Department of Public Health Department of Health http://mass.gov/dph/dcp ASAP 4/2007 ASAP 4-1/2010 ASAP 4-2/2011 Pharmacy in-state Pharmacy out-state/mail order Pharmacy out-state other Dispensing doctor Massachusetts Contact Information Allwes, Deborah - Director 99 Chauncy Street Boston MA 02111 Office: (617) 753-8062 Fax: Email: Technological Capabilities Electronic data transmissio Fax data transmission Mail data transmission Media data transmission Required Data Transmitters Veterinarian Veterans Administration Indian Health Services deborah.allwes@state.ma.us Data Transmission Methods Allowed Other data transmission Other: Data Collection Entity: Vendor Vendor name: Atlantic Associates Inc. Data Storage Entity: In-House Vendor name: In-House Report Generation Entity: In-House Vendor name: In-House Data Access Method: Web Portal/On-Line Statistics Data Collection, Storage, Generation and Access Data Access Entity: In-House Vendor name: In-House PDMP region: Statistics Year: 2014 DEA Registered Prescribers: 44,323 State population: 6,745,408 DEA Registered Dispensers: 1,175 East

Interstate data sharing PMPi Hub RxCheck Hub RxSentry Hub HIE method Other Hub Data Access via Health Information Exchang via Electronic Health Recor via Pharmacy Dispensing Syste Controlled Schedules Monitored Schedule II monitored Schedule III monitored Schedule IV monitored Schedule V monitored Data Collection and Dates Collection frequency: 1 Legislation enacted: 1992 PDMP operational 1994 Data Sharing List of states involved in sharing: Impediments to data sharing: Currently developing MOUs (KY, CT and others) to share data through Hub; IT group sets priorities and timelines for this project Patient Matching Exact Match Probablistic/Manual Matc Probablistic Match Other Match for queries Wild card searching available. First 5 letters of first name plus asterick and first 2 letters of last name plus asterisk. Policies and Procedures Monitor other authority Remove from Monitoring Web 24/7 Fax 24/7 Web Business Hours Fax Business Hours Other Other Substances Monitored Data Request Methods and Hours of Operation Phone Business Hours Email Business Hours Mail Business Hours In-Person Business Hours Other Law/Rule Website: Law/Statute citation: MA Gen Laws Chapter 94C 24A & 49; Chapter 66A 2 Regulation/Rule citation: MA Code Regs 105-700.006 and.012; 247-5.01 to.04 Dr Shopper law/statute: Pill Mill law/statute: Pain Clinic law/statute: Relevant Statutes and Rules http://www.mass.gov/eohhs/gov/departments/dph/programs/hcq/drug-control/drugcontrol/public-health-regulations-drug-control.html Disclosure law/statute: MA Code Regs 105 700.012(3); Chapter 94c Section 38 Data Retention Policy All Information Purged Data Retention Time: Record Retention Details: De-Identified Data Retention Details: Prescriber Information Purged Dispenser Information Purged Data Retention Patient Information Purged Drug Information Purged Retain De-Identified Data

Required Enrollment - Prescriber Required Enrollment - Dispenser PDMP Required Enrollment and Patient Query Required Patient Query - Prescriber Required Patient Query - Dispenser Required Patient Query Details: By law the Department is required to register practitioners (dentists, physicians, pharmacists, Pas, nurses and podiatrists) who are obtaining a new Massachusetts Controlled Substance Registration (MCSR) or whose MCSR is being recalled for reissuance. Requires licensees to check the PMP prior to prescribing a hydrocodone-only extended release medication in a non-abuse deterrent formula; Requires practitioners to query the PMP 1) annually for patients who are receiving ongoing treatment with an opiate in Schedule II-IV; 2) when starting a patient on an opiate for non-palliative, long-term pain therapy of 90 days or more; 3) the first time the practitioner prescribes an opiate for chronic pain; 4) prior to writing a replacement prescription for an opiate; and 5) any other scenario mandated by the department through regulation Select Data Fields Available Payment method captured Patient Identification captured Person dropping off captured Person picking up captured Ability to id prescriber specialty Prescriber: Dispenser: Regulatory Board: Law Enforcement: Attorney General: Researcher: Patient: Other: Miscellaneous Capabilities and Policies Authority to release de-identified data Ability to de-identified data Authority to release for epidemiological or educational purposes Engaged in release for epidemiological or educational purposes Required Notification to consumers Mandated Use of Advisory Group Patient Access to Query List Requirements to Query PDMP must have DEA Registration number and Massachusetts Controlled Substances Registration number to register Prescriber Access to Patient History Prescriber Access to Own History Dispenser Access to Patient History Dispenser Access to Own History PDMP Available Reports Available Reports to Selected Requestors Licensing Board Access to Patient History Licensing Board Access to Licensee History Law Enforcement Access to Patient History Law Enforcement Access to Prescriber History Law Enforcement Access to Dispenser History

Requestors and Reports Authorized to Generate Requestor Type Prescriber Dispenser/Business (i.e., pharmacy) Dispenser/Person (i.e., pharmacist) Midlevel - Physician Assistant Midlevel - Nurse Practitioner Prescriber Delegate Dispenser Delegate Patient Law Enforcement - Federal Law Enforcement - State Law Enforcement - Local Prosecutorial Authority Correctional Supervision Drug Court Licensing/Regulatory Board State Health Department Medicaid Fraud and Abuse Medicaid Drug Utilization and Review Medicare Workers Compensation - State Workers Compensation - Insurance Peer Review Committee Drug Treatment Provider Third-party Payer Researchers Other PDMP Solicited Reports Unsolicited Reports In-State Out-of-State In-State Out-of-State

Requestors and Reports Being Generated Requestor Type Prescriber Dispenser/Business (i.e., pharmacy) Dispenser/Person (i.e., pharmacist) Midlevel - Physician Assistant Midlevel - Nurse Practitioner Prescriber Delegate Dispenser Delegate Patient Law Enforcement - Federal Law Enforcement - State Law Enforcement - Local Prosecutorial Authority Correctional Supervision Drug Court Licensing/Regulatory Board State Health Department Medicaid Fraud and Abuse Medicaid Drug Utilization and Review Medicare Workers Compensation - State Workers Compensation - Insurance Peer Review Committee Drug Treatment Provider Third-party Payer Researchers Other PDMP Solicited Reports Unsolicited Reports In-State Out-of-State In-State Out-of-State